Patents Assigned to Binyarco, LLC
  • Patent number: 9248186
    Abstract: A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline. The composition is preferably a paste administered intranasally.
    Type: Grant
    Filed: October 30, 2012
    Date of Patent: February 2, 2016
    Assignee: BINYARCO, LLC
    Inventor: Jeffrey E. Binder
  • Publication number: 20130052251
    Abstract: A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline. The composition is preferably a paste administered intranasally.
    Type: Application
    Filed: October 30, 2012
    Publication date: February 28, 2013
    Applicant: BINYARCO, LLC
    Inventor: BINYARCO, LLC
  • Patent number: 8304402
    Abstract: A composition and method for treating nosebleed, that is, epistaxis. The composition comprises bismuth subgallate and a vasoconstriction agent, preferably oxymetazoline. The composition is preferably a paste administered intranasally.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: November 6, 2012
    Assignee: Binyarco, LLC
    Inventor: Jeffrey E. Binder
  • Patent number: D868251
    Type: Grant
    Filed: April 12, 2017
    Date of Patent: November 26, 2019
    Assignee: BINYARCO, LLC
    Inventor: Jeffrey E. Binder
  • Patent number: D945614
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: March 8, 2022
    Assignee: BINYARCO, LLC
    Inventor: Jeffrey E. Binder